Seller record · Telehealth service

Measured

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S3, pharmacy identification: The site names no filling pharmacy. The pages say prescriptions are filled by independent, state-licensed pharmacies, and the terms, the privacy policy and the safety page name none. 1 more criterion also fails; see the table below.

At a glance

MeasuredTelehealth service

6/8criteria passed

Price: Semaglutide from $119 a month, tirzepatide from $219, medication included
Sells: compounded semaglutide, compounded tirzepatide, GLP-1 microdose, and 7 more
FDA letters: 1 on file

Visit Measured See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A weight care service selling compounded semaglutide and tirzepatide, a GLP-1 microdose and brand GLP-1 drugs, alongside NAD+, sermorelin, glutathione, B12 with MIC and an oxytocin nasal spray. An FDA warning letter of February 2026 names the company, and its pages name no filling pharmacy.

Operating entity Better Health Labs, Inc.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Measured's website; Measured's terms
S2	Prescription gating	PASS	Measured's weight loss goal page on its quiz storefront; Measured's GLP-1 microdose product page
S3	Pharmacy identification	FAIL	Measured's website; Measured's terms; Measured's safety page
S4	Compounding disclosure	PASS	Measured's GLP-1 microdose product page; Measured's sermorelin product page
S5	Analytical documentation	FAIL	Measured's medications page; Measured's safety page
S6	Business address	PASS	Measured's website; Measured's terms; Measured's privacy page
S7	Price disclosure	PASS	Measured's medications page; Measured's website; Measured's GLP-1 microdose product page; Measured's NAD+ product page; Measured's wegovy pill product page
S8	Enforcement status	PASS	fda.gov; letter 721454

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed provider reviews each assessment and creates the treatment plan, and the terms name the Coastal Care Medical Group practices in Florida, California and New Jersey as its affiliated medical groups.Source: Measured's website; Measured's terms.

S2PASSThe eligibility button opens a quiz whose first screen asks how much weight the buyer wants to lose.Source: Measured's weight loss goal page on its quiz storefront; Measured's GLP-1 microdose product page.

S3FAILThe site names no filling pharmacy. The pages say prescriptions are filled by independent, state-licensed pharmacies, and the terms, the privacy policy and the safety page name none.Source: Measured's website; Measured's terms; Measured's safety page.

S4PASSEach compounded product page states that compounded medications are not FDA-approved for safety, efficacy or quality, beside the price.Source: Measured's GLP-1 microdose product page; Measured's sermorelin product page.

S5FAILNo certificate of analysis or lot document is published on the product pages, the safety page, the terms or the privacy policy.Source: Measured's medications page; Measured's safety page.

S6PASSBetter Health Labs, Inc. at 169 Madison Ave #2012, New York, NY 10016, printed in the footer of every page, in the terms and in the privacy policy.Source: Measured's website; Measured's terms; Measured's privacy page.

S7PASSCompounded semaglutide from $119 a month and compounded tirzepatide from $219 a month, medication included. The GLP-1 microdose from $79 a month for semaglutide, shown against a struck-through $99, and from $129 for tirzepatide. NAD+ and the oxytocin nasal spray from $159 a month against a struck-through $199, sermorelin and B12 with MIC from $149 against $199, and glutathione from $129 against $159. Brand GLP-1 plans carry a membership from $49 a month with the medication priced separately, and the Wegovy pill page shows that membership against a struck-through $129.Source: Measured's medications page; Measured's website; Measured's GLP-1 microdose product page; Measured's NAD+ product page; Measured's wegovy pill product page.

S8PASSFDA warning letter 721454, February 2026, names Better Health Labs, Inc. dba Measured at the New York address the site prints, alleging that pictured labels presented Measured as the compounder of its semaglutide and tirzepatide and that claims of the same active ingredient as the brand drugs implied FDA approval. No FDA action has halted the business, and the seller still trades.Source: fda.gov; letter 721454.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, GLP-1 microdose, brand Wegovy pen and pill, brand Zepbound, NAD+, sermorelin, glutathione, B12 + MIC, oxytocin nasal spray.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+Who sells glutathione

Enforcement documents on file: 1 warning letter

FDA warning letter 721454, issued February 2026, to Better Health Labs, Inc. dba MeasuredPictured labels identify Measured as the compounder of semaglutide and tirzepatide products when it is not, and claims of the same active ingredient as Wegovy, Ozempic, Zepbound and Mounjaro imply the products are FDA-approved.

A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.

Visit Measured

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.